Ebru Emekli-Alturfan, G⃞l⃞en ⃞zdemira, Esra Sağlam, Emine Nur ⃞zdamar, ⃞zer ⃞ehirli and G⃞ksel ⃞enerc
. Therapeutic effect of captopril, pentoxifylline, and cordyceps sinensis in pre-hepatic portal hypertensive rats. Saudi J Gastroenterol. 2012; 18:182-7.
38. Ha H, Kim KH. Amelioration of diabetic microalbuminuria and lipid peroxidation by captopril.Yonsei Med J. 1992; 33:217-23.
39. Rodrigues de Araujo G, Granato de Faria K, Lima WG, Padua BD, Rossoni JV, Souza AA, et al. Effect of captopril and the bradykinin-PKC pathway on ROS production in type 1 diabetic rats. Can J Physiol Pharmacol. 2011; 89:923-33.
40. Jolly SR, Kane WJ
present. However, their benefit for cardiovascular disease, which is prevalent in NAFLD populations, should not be overlooked [ 68 ].
The recommended treatments according to the 2018 AASLD guidelines are weight reduction, vitamin E, and pioglitazone in non-diabetic adults with biopsy-proven NASH [ 1 ]. Despite the established recommendation, there are several ongoing investigations of other drugs such as glucagon-like peptide 1 agonists, statins, pentoxifylline, and obeticholic acid [ 36 , 69 ]. One of the key confounders of the included studies is the lack of